UnitedHealth Group Incorporated (NYSE:UNH) Position Decreased by Grant GrossMendelsohn LLC

Grant GrossMendelsohn LLC decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 35.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 410 shares of the healthcare conglomerate’s stock after selling 225 shares during the period. Grant GrossMendelsohn LLC’s holdings in UnitedHealth Group were worth $201,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently made changes to their positions in the company. TimeScale Financial Inc. boosted its position in shares of UnitedHealth Group by 276.9% during the 3rd quarter. TimeScale Financial Inc. now owns 49 shares of the healthcare conglomerate’s stock valued at $25,000 after purchasing an additional 36 shares in the last quarter. Pflug Koory LLC boosted its holdings in shares of UnitedHealth Group by 160.0% in the third quarter. Pflug Koory LLC now owns 52 shares of the healthcare conglomerate’s stock worth $26,000 after buying an additional 32 shares during the period. Belmont Capital LLC boosted its holdings in shares of UnitedHealth Group by 294.1% in the third quarter. Belmont Capital LLC now owns 67 shares of the healthcare conglomerate’s stock worth $34,000 after buying an additional 50 shares during the period. O Dell Group LLC boosted its holdings in shares of UnitedHealth Group by 76.9% in the third quarter. O Dell Group LLC now owns 69 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 30 shares during the period. Finally, Legend Financial Advisors Inc. acquired a new position in shares of UnitedHealth Group in the third quarter worth about $37,000. Institutional investors own 86.31% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft raised their target price on shares of UnitedHealth Group from $615.00 to $617.00 and gave the stock a “buy” rating in a report on Tuesday, January 24th. Morgan Stanley reissued an “overweight” rating and issued a $587.00 price target on shares of UnitedHealth Group in a research report on Wednesday, November 23rd. Raymond James lowered shares of UnitedHealth Group from a “strong-buy” rating to an “outperform” rating and set a $615.00 price target for the company. in a research report on Monday, November 21st. UBS Group reduced their price target on shares of UnitedHealth Group from $590.00 to $550.00 and set a “neutral” rating for the company in a research report on Wednesday, January 18th. Finally, Stephens reissued an “overweight” rating and issued a $605.00 price target on shares of UnitedHealth Group in a research report on Tuesday, February 28th. Three investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $599.68.

UnitedHealth Group Trading Down 0.5 %

NYSE:UNH opened at $469.50 on Friday. UnitedHealth Group Incorporated has a 12 month low of $449.70 and a 12 month high of $558.10. The firm has a market cap of $437.97 billion, a price-to-earnings ratio of 22.16, a P/E/G ratio of 1.30 and a beta of 0.69. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.67. The company’s 50 day moving average is $483.26 and its 200-day moving average is $510.78.

UnitedHealth Group (NYSE:UNH – Get Rating) last released its quarterly earnings results on Friday, January 13th. The healthcare conglomerate reported $5.34 EPS for the quarter, beating analysts’ consensus estimates of $5.17 by $0.17. The company had revenue of $82.79 billion for the quarter, compared to analyst estimates of $82.53 billion. UnitedHealth Group had a net margin of 6.21% and a return on equity of 27.04%. The company’s quarterly revenue was up 12.3% compared to the same quarter last year. During the same quarter last year, the firm posted $4.48 earnings per share. Equities analysts anticipate that UnitedHealth Group Incorporated will post 24.91 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 21st. Stockholders of record on Monday, March 13th will be paid a $1.65 dividend. The ex-dividend date is Friday, March 10th. This represents a $6.60 annualized dividend and a dividend yield of 1.41%. UnitedHealth Group’s payout ratio is 31.15%.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.